SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-19-014209
Filing Date
2019-12-26
Accepted
2019-12-26 08:46:06
Documents
17
Period of Report
2019-12-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tgtx-20191231.htm   iXBRL 8-K 32640
2 OPINION OF ALSTON & BIRD LLP tgtx_ex51.htm EX-5.1 13521
3 FORM OF SECURITIES PURCHASE AGREEMENT tgtx_ex991.htm EX-99.1 85320
4 GRAPHIC tgtx_ex51000.jpg GRAPHIC 7212
  Complete submission text file 0001654954-19-014209.txt   284692

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE tgtx-20191231.xsd EX-101.SCH 2979
6 XBRL PRESENTATION FILE tgtx-20191231_pre.xml EX-101.PRE 11172
7 XBRL LABEL FILE tgtx-20191231_lab.xml EX-101.LAB 15312
8 XBRL DEFINITION FILE tgtx-20191231_def.xml EX-101.DEF 1885
9 XBRL CALCULATION FILE tgtx-20191231_cal.xml EX-101.CAL 886
15 EXTRACTED XBRL INSTANCE DOCUMENT tgtx-20191231_htm.xml XML 4131
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32639 | Film No.: 191308426
SIC: 2834 Pharmaceutical Preparations